April 7, 2017
Pat Devitt Risse in Life Science Leader: Bet On Biomarkers for Better OutcomesRead more...
March 1, 2017
Precision Oncology’s Messerschmidt on Protocol Development in PharmaVOICEDiscover more...
February 21, 2017
Commentary: The Challenges of Harmonizing Biomarker Data: Why Trial Success Depends on ItGet the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of concept to drug approval.
Precision Oncology’s Messerschmidt on Protocol Development in PharmaVOICE
Precision Oncology’s Dr. Gerald Messerschimdt discusses clinical protocol develo... Discover more »
Briefing: Best Practices for the Expedited Start-Up of Oncology Trials
Precision subject matter expert, Tandy Tipps, highlights how oncology sites can... Discover more »
Pat Devitt Risse in Life Science Leader: Bet On Biomarkers for Better Outcomes
Perspective: Convergence of CLIA and FDA Requirements: A Rationale Shift in the Regulatory Paradigm
The laboratory developed test (LDT) has proven to be a flexible, quick, lower-in... Discover more »
6 Critical Factors for Achieving Approval of Oncology Drugs
In this high-stakes, high-velocity environment of oncology drug development and... Discover more »